Tag Archives: Shobha Shukla

Scientific research has gifted us with a range of evidence-based options to protect ourselves from getting infected with HIV. In 2012, the U.S. Food and Drugs Authority (FDA) had first approved Pre-Exposure Prophylaxis (PrEP) daily oral medicines for HIV prevention. More recently, long-acting injectable options of PrEP are also approved. …

But it poses an inconvenient question: is it expanding choices for the people? ANALYSIS | SHOBHA SHUKLA | Any new HIV prevention method is not meant to sit on the shelf but to be used by the people who need it to protect themselves from HIV. We have to ensure that …

How they fuel antimicrobial resistance ANALYSIS | SHOBHA SHUKLA | When we go to seek healthcare in hospitals or other healthcare settings, getting infected with hospital-acquired infections instead, is not part of the deal. “Why are hospital-acquired infections so acceptable?” rightly questions Dr Nour Shamas, a Lebanese infectious disease clinical pharmacist, …

WHO charts new path for action against antimicrobial resistance (AMR) ANALYSIS | SHOBHA SHUKLA |  Protect the medicines that protect us and ensure that all those who need them can access them, says Dr Tedros Adhanom Ghebreyesus, the Director General of The World Health Organization (WHO). He was speaking at a …